Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators. Diener HC, et al. Among authors: masjuan j. N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959. N Engl J Med. 2019. PMID: 31091372 Clinical Trial.
Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data.
Ferro JM, Crassard I, Coutinho JM, Canhão P, Barinagarrementeria F, Cucchiara B, Derex L, Lichy C, Masjuan J, Massaro A, Matamala G, Poli S, Saadatnia M, Stolz E, Viana-Baptista M, Stam J, Bousser MG; Second International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT 2) Investigators. Ferro JM, et al. Among authors: masjuan j. Stroke. 2011 Oct;42(10):2825-31. doi: 10.1161/STROKEAHA.111.615393. Epub 2011 Jul 28. Stroke. 2011. PMID: 21799156 Review.
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).
Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Secades JJ; International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. Dávalos A, et al. Among authors: masjuan j. Lancet. 2012 Jul 28;380(9839):349-57. doi: 10.1016/S0140-6736(12)60813-7. Epub 2012 Jun 11. Lancet. 2012. PMID: 22691567 Free article. Clinical Trial.
Dabigatran in secondary stroke prevention: clinical experience with 106 patients.
DeFelipe-Mimbrera A, Alonso Cánovas A, Guillán M, Matute C, Sainz de la Maza S, Cruz A, Vera R, Masjuan J. DeFelipe-Mimbrera A, et al. Among authors: masjuan j. Biomed Res Int. 2014;2014:567026. doi: 10.1155/2014/567026. Epub 2014 Jul 15. Biomed Res Int. 2014. PMID: 25133166 Free PMC article.
Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke Patients.
Purroy F, Vena A, Forné C, de Arce AM, Dávalos A, Fuentes B, Arenillas JF, Krupinski J, Gómez-Choco M, Palomeras E, Martí-Fábregas J, Castillo J, Ustrell X, Tejada J, Masjuan J, Garcés M, Benabdelhak I, Serena J. Purroy F, et al. Among authors: masjuan j. Cerebrovasc Dis. 2019;47(3-4):151-164. doi: 10.1159/000500205. Epub 2019 May 3. Cerebrovasc Dis. 2019. PMID: 31055571
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients.
Ros-Castelló V, Natera-Villalba E, Gómez-López A, Sánchez-Sánchez A, Chico-García JL, García-Madrona S, Vera-Lechuga R, Matute-Lozano C, de Felipe Mimbrera A, Cruz-Culebras A, Alonso-Canovas A, Masjuan J. Ros-Castelló V, et al. Among authors: masjuan j. Cerebrovasc Dis Extra. 2020;10(3):166-173. doi: 10.1159/000511064. Epub 2020 Nov 11. Cerebrovasc Dis Extra. 2020. PMID: 33176324 Free PMC article.
COVID-19: patients with stroke or risk of stroke.
Diener HC, Berlit P, Masjuan J. Diener HC, et al. Among authors: masjuan j. Eur Heart J Suppl. 2020 Dec 23;22(Suppl Pt t):P25-P28. doi: 10.1093/eurheartj/suaa174. eCollection 2020 Dec. Eur Heart J Suppl. 2020. PMID: 33390866 Free PMC article.
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
Shoamanesh A, Mundl H, Smith EE, Masjuan J, Milanov I, Hirano T, Agafina A, Campbell B, Caso V, Mas JL, Dong Q, Turcani P, Christensen H, Ferro JM, Veltkamp R, Mikulik R, De Marchis GM, Robinson T, Lemmens R, Stepien A, Greisenegger S, Roine R, Csiba L, Khatri P, Coutinho J, Lindgren AG, Demchuk AM, Colorado P, Kirsch B, Neumann C, Heenan L, Xu L, Connolly SJ, Hart RG; PACIFIC-Stroke Investigators. Shoamanesh A, et al. Among authors: masjuan j. Lancet. 2022 Sep 24;400(10357):997-1007. doi: 10.1016/S0140-6736(22)01588-4. Epub 2022 Sep 2. Lancet. 2022. PMID: 36063821 Clinical Trial.
Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
Smith EE, Shoamanesh A, Xu L, Heenan L, Saad F, Colorado P, Chen CH, Lemmens R, De Marchis GM, Caso V, Masjuan J, Hirano T, Milanov I, Campbell BCV, Mas JL, Connolly SJ, Mundl H, Hart RG; PACIFIC-Stroke Steering Committee and Investigators. Smith EE, et al. Among authors: masjuan j. Stroke. 2024 Feb;55(2):392-402. doi: 10.1161/STROKEAHA.123.043198. Epub 2024 Jan 4. Stroke. 2024. PMID: 38174569 Clinical Trial.
211 results